MIXR supports the development and scientific foundations for designing and assessing extended-reality (XR) applications in medicine. Collaborating with our industry partners and regulatory scientists, we are exploring the use of XR to improve public health and healthcare outcomes across education and simulation, clinical care delivery, and applying data science and machine learning to improve diagnosis and therapeutics.
MIXR has specifically identified driving applications in clinical practice, medical education and training, and regulatory standards. In service of these, we bring unique capabilities in scene acquisition, predictive modeling, immersive telepresence, human factors, and imaging and displays.
Amitabh Varshney
Center Director, University of Maryland, College Park
+1 301 405 2316
varshney@umd.edu
Sarah B Murthi
Site Director, University of Maryland, Baltimore
+1 410 328 6704
smurthi@umm.edu
Rishindra Reddy
Site Director, University of Michigan
+1 734 936 5738
reddyrm@med.umich.edu
Mark S Cohen
Dean, Carle Illinois College of Medicine
+1 217 300 5700
meddean@illinois.edu
MIXR has specifically identified driving applications in clinical practice, medical education and training, and regulatory standards. In service of these, we bring unique capabilities in scene acquisition, predictive modeling, immersive telepresence, human factors, and imaging and displays. Beyond these applications, we are interested in evaluating metrics and usability, 5G/6G, artificial intelligence (AI) and machine learning (ML), and displays for XR devices in healthcare applications. Working with the U.S. Food and Drug Administration (FDA) and other regulatory and standards agencies, we address open research questions in these areas. Program outcomes will provide the scientific foundation in support of regulatory requirements and decisions regarding XR devices; our focus will be on current gaps and evaluation challenges across a range of clinical specialties and various XR hardware and software platforms. Bridging the gaps currently preventing the ubiquitous use of XR could decrease medical errors and save lives, and thus have a substantial economic impact on medicine.
This external link provides additional information that is consistent with the intended purpose of this site. NSF cannot attest to the accuracy of a non-federal site.
Linking to a non-federal site does not constitute an endorsement by NSF or any of its employees of the sponsors or the information and products presented on the site.
You will be subject to the destination site's privacy policy when you follow the link.